Chinese Colorectal Cancer Drug Market Will More Than Double by 2012
Posted on: Monday, 13 April 2009, 07:00 CDT
Modest Increase in Market Share Expected for Western Drug Companies, According to a Report from Decision Resources
"The increased use of Merck KGaA's Erbitux and Jiangsu Simcere's Endostar and the launch of Roche's Avastin will be the strongest drivers of the Chinese colorectal drug market during the next five years," stated
The new Emerging Markets report entitled Colorectal Cancer in China also finds that modest increase in market share is expected for Western drug companies by 2012. This growth will result from the increased uptake of Western-branded, targeted agents and the decreasing market share of conventional chemotherapy drugs owing to fierce competition from domestic products. The report contains primary research of physicians and epidemiology study in key pharmaceutical markets of
About Emerging Markets Reports
Decision Resources is the FIRST and ONLY company to offer a syndicated report series for high-growth emerging markets with comprehensive disease-specific analysis. Each report assesses the commercial opportunity in the pharmaceutical market for a disease based on population demographics, economic development, disease epidemiology and changing physicians' practices.
About Decision Resources
Decision Resources (www.DecisionResources.com) is a world leader in market research publications, advisory services and consulting designed to help clients shape strategy, allocate resources and master their chosen markets. Decision Resources is a Decision Resources, Inc. company.
About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.
All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.
For more information, contact:
Natalia Morales Elizabeth Marshall Decision Resources Decision Resources, Inc. 781-296-2691 781-296-2563 nmorales@dresources.com emarshall@dresources.comSOURCE Decision Resources
Source: PR Newswire
Related Articles
- Market Potential for Hospital Services, Pharmaceuticals and Medical Devices in the US
- Innovative Drug Discovery Strategies Are Critical to the Growth of Pharmaceutical R&D Productivity
- AVANIR Receives FDA Approval for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
- Avanir Receives FDA Approvable Letter for New Formulation of Currently Marketed Antipsychotic Drug FazaClo
- Worldwide Telecommunications Service Provider Equipment Market Forecasts Indicate That the Market Will Be Worth $64.3 Billion By 2012
- CombinatoRx to Present at the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference
- SGX Pharmaceuticals to Present at the CIBC World Markets Annual Biotechnology and Specialty Pharmaceuticals Conference
- CORRECTING and REPLACING PC Market Continues Rapid Growth In Fourth Quarter of 2005 As Annual Shipments Reach New Highs, According to IDC
- '2006 US Market Advanced Drug Delivery Systems Probing the Route to Growth' Provides Readers With Information and Analysis About Key Developments Driving the Industry in the Middle of 2005
- Ethernet Switch Market Resumes Strong Growth in 3Q04, According to Dell'Oro Group; Both Bandwidth and Feature Upgrades Drive Increase
 |
 |
User Comments (0)
RSS Feeds